Research News and Research

RSS
New therapeutic vaccines help kick drug habits

New therapeutic vaccines help kick drug habits

New drug target for the treatment of Parkinson's disease

New drug target for the treatment of Parkinson's disease

Toronto at forefront of stem cell technology

Toronto at forefront of stem cell technology

Morning sickness may indicate lower risk of breast cancer

Morning sickness may indicate lower risk of breast cancer

New hope for Alzheimer's disease

New hope for Alzheimer's disease

Parents of chronically ill kids are helped by better access to federal and employer leave

Parents of chronically ill kids are helped by better access to federal and employer leave

Omega-3 fatty acids appear to slow prostate cancer

Omega-3 fatty acids appear to slow prostate cancer

Novel method of drug delivery to inhibit the growth of prostate cancer cells

Novel method of drug delivery to inhibit the growth of prostate cancer cells

Study to investigate how dietary iron is used by cells

Study to investigate how dietary iron is used by cells

Meaningful leisure can mean many things

Meaningful leisure can mean many things

Insight into how cancerous tumors thrive

Insight into how cancerous tumors thrive

Invertebrate immune systems are anything but simple

Invertebrate immune systems are anything but simple

Why NSAIDs damage the tissue that lines the gastrointestinal tract

Why NSAIDs damage the tissue that lines the gastrointestinal tract

Inherited genes linked to toxicity of leukemia therapy

Inherited genes linked to toxicity of leukemia therapy

Scientists identify gene responsible for one type of Charcot-Marie-Tooth disorder

Scientists identify gene responsible for one type of Charcot-Marie-Tooth disorder

U.S. FDA approves Lyrica (pregabalin), the first drug to treat fibromyalgia

U.S. FDA approves Lyrica (pregabalin), the first drug to treat fibromyalgia

Tamiflu could halve the pandemic influenza death toll versus no intervention

Tamiflu could halve the pandemic influenza death toll versus no intervention

Arpida receives FDA approval to initiate Phase II trial with intravenous iclaprim

Arpida receives FDA approval to initiate Phase II trial with intravenous iclaprim

Review of the routine monitoring of growth in children of primary school age to identify growth-related conditions

Review of the routine monitoring of growth in children of primary school age to identify growth-related conditions

New understanding of modern pandemic infection

New understanding of modern pandemic infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.